Aadi Bioscience (NASDAQ:AADI – Get Free Report) posted its quarterly earnings data on Tuesday. The company reported ($0.67) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.31) by ($0.36), Zacks reports. Aadi Bioscience had a negative return on equity of 71.87% and a negative net margin of 246.06%.
Aadi Bioscience Price Performance
Shares of AADI stock traded down $0.04 during trading hours on Tuesday, reaching $2.06. 49,245 shares of the stock were exchanged, compared to its average volume of 244,689. The business’s fifty day moving average is $2.73 and its two-hundred day moving average is $2.40. The firm has a market capitalization of $50.80 million, a P/E ratio of -0.90 and a beta of 0.68. Aadi Bioscience has a 12-month low of $1.21 and a 12-month high of $3.81.
Aadi Bioscience Company Profile
Further Reading
- Five stocks we like better than Aadi Bioscience
- Airline Stocks – Top Airline Stocks to Buy Now
- Arqit Stock Soars as NVIDIA’s GTC Fuels Quantum Excitement
- How to Invest in Insurance Companies: A Guide
- 3 Must-Own Stocks to Build Wealth This Decade
- Breakout Stocks: What They Are and How to Identify Them
- Advanced Micro Devices Eyes AI Market Growth—Is AMD a Buy?
Receive News & Ratings for Aadi Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aadi Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.